Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AGK-BRAF fusion
i
Other names:
AGK, Acylglycerol Kinase, Multiple Substrate Lipid Kinase, Acylglycerol Kinase, Mitochondrial, Multi-Substrate Lipid Kinase, HsMuLK, MULK, HAGK, MTDPS10, CATC5, BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
673
;
55750
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
KIAA1549-BRAF fusion (10)
BRAF fusion (9)
SKAP2-BRAF fusion (4)
TARDBP-BRAF fusion (4)
FKBP15-BRAF fusion (3)
PPFIBP2-BRAF fusion (3)
CUL1-BRAF fusion (2)
SLC45A3-BRAF fusion (2)
SND1-BRAF fusion (2)
BRAF-MAD1L1 fusion (1)
BRAF-ZC3H7A fusion (1)
CUX1-BRAF fusion (1)
EXOC4-BRAF fusion (1)
NRF1-BRAF fusion (1)
TRIM33-BRAF fusion (1)
ZKSCAN1-BRAF fusion (1)
KIAA1549-BRAF fusion (10)
BRAF fusion (9)
SKAP2-BRAF fusion (4)
TARDBP-BRAF fusion (4)
FKBP15-BRAF fusion (3)
PPFIBP2-BRAF fusion (3)
CUL1-BRAF fusion (2)
SLC45A3-BRAF fusion (2)
SND1-BRAF fusion (2)
BRAF-MAD1L1 fusion (1)
BRAF-ZC3H7A fusion (1)
CUX1-BRAF fusion (1)
EXOC4-BRAF fusion (1)
NRF1-BRAF fusion (1)
TRIM33-BRAF fusion (1)
ZKSCAN1-BRAF fusion (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
AGK-BRAF fusion
Melanoma
AGK-BRAF fusion
Melanoma
FORE-8394
Resistant: C4 – Case Studies
FORE-8394
Resistant
:
C4
FORE-8394
Resistant: C4 – Case Studies
FORE-8394
Resistant
:
C4
AGK-BRAF fusion
Melanoma
AGK-BRAF fusion
Melanoma
tovorafenib
Sensitive: C4 – Case Studies
tovorafenib
Sensitive
:
C4
tovorafenib
Sensitive: C4 – Case Studies
tovorafenib
Sensitive
:
C4
AGK-BRAF fusion
Melanoma
AGK-BRAF fusion
Melanoma
sorafenib
Sensitive: D – Preclinical
sorafenib
Sensitive
:
D
sorafenib
Sensitive: D – Preclinical
sorafenib
Sensitive
:
D
AGK-BRAF fusion
Melanoma
AGK-BRAF fusion
Melanoma
dabrafenib
Resistant: D – Preclinical
dabrafenib
Resistant
:
D
dabrafenib
Resistant: D – Preclinical
dabrafenib
Resistant
:
D
AGK-BRAF fusion
Melanoma
AGK-BRAF fusion
Melanoma
vemurafenib
Resistant: D – Preclinical
vemurafenib
Resistant
:
D
vemurafenib
Resistant: D – Preclinical
vemurafenib
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.